Precision Medicine will need to get out of the pharma silo that is based on symptoms

Welcome to the digital era of biology (and to this modest blog I started in early 2005).

To cure many diseases, like cancer or cystic fibrosis, we will need to target genes (mutations, for ex.), not organs! I am convinced that the future of replacement medicine (organ transplant) is genomics (the science of the human genome). In 10 years we will be replacing (modifying) genes; not organs!

Anticipating the $100 genome era and the P4™ medicine revolution. P4 Medicine (Predictive, Personalized, Preventive, & Participatory): Catalyzing a Revolution from Reactive to Proactive Medicine.

After low-cost airlines (Ryanair, Easyjet ...) comes "low-cost" participatory medicine. Some of my readers have recently christened this long-lasting, clumsy attempt at e-writing of mine "THE LOW-COSTE INNOVATION BLOG". I am an
early adopter of scientific MOOCs. My name's Catherine Coste. I've earned myself four MIT digital diplomas: 7.00x, 7.28x1, 7.28.x2 and 7QBWx. Instructor of 7.00x: Eric Lander PhD.

Upcoming books: Airpocalypse, a medical thriller (action taking place in Beijing) 2017; Jesus CRISPR Superstar, a sci-fi -- French title: La Passion du CRISPR (2018).

I love Genomics. Would you rather donate your data, or... your vital organs?

Audio files on this blog are Windows files ; if you have a Mac, you might want to use VLC ( to read them.

Concernant les fichiers son ou audio (audio files) sur ce blog : ce sont des fichiers Windows ; pour les lire sur Mac, il faut les ouvrir avec VLC (

The DNA Microcredit Revolution: Donate your Data in India thanks to microcredit

Meet the Made-in-India Cancer Genome Project: Donate your DNA data, thanks to microcredit
Microfinance for DNA Data Sharing
Using Microcredit (microfinance) for some made-in-India Human Cancer Genome Project?
Wanna get some better, affordable and personalized medicine?

We can donate our vital organs upon our death... Now it seems that we can even donate... our data.

"Our project aims to enable citizens to donate their data upon their death."

But... why wait for somebody's death??

I dunno if you are familiar with India and Bangladesh -- well I am a tiny bit. You find people all over the place, willing to sell their hair (women, for the worldwide hair extension market), their blood, a kidney (er that one falls under the organ trafficking category), etc.

Now how about cancer and healthy (but not wealthy) patients who could trade their DNA data for some rice or medicine or... a microloan?

Remember the microcredit (microfinance)? Muhammad Yunus was awarded the Nobel Peace Prize in 2006 for his work providing microcredit services to the poor.

Would you rather give your data, or... a vital organ?

The speed of progress in the human genome science is mind blowing... However, curing cancer will request a lot of sharing work from patients worldwide... India is a good place to start... 

Big Pharma / Big Biotech are both powerful and greedy. Any power calls for a counter-power. With no counter-power at all, "big pharma" is very likely to turn into "pig pharma" -- consuming Chinese human guinea pigs, that is...

"Medical student Pia Grazdani decides to take a year off from her studies and escape New York City. Intrigued by the promise of the burgeoning field of medical technology, Pia takes a job at Nano, LLC, a lavishly funded, security-conscious nanotechnology institute in the picturesque foothills of the Rocky Mountains in Colorado. Nano, LLC is ahead of the curve in the competitive world of molecular manufacturing, including the construction of microbivores, tiny nano-robots with the ability to gobble up viruses and bacteria. But the corporate campus is a place of secrets. When Pia encounters a fellow employee on a corporate jogging path suffering the effects of a seizure, she soon realizes she may have literally stumbled upon one of Nano, LLC's human guinea pigs. Is the tech giant on the cusp of one of the biggest medical discoveries of the twenty-first century – a treatment option for millions – or have they already sold out to the highest bidder?" (Amazon)

1 commentaire:

Low-Coste Innovation Blog a dit…